Summary
Invesco Dorsey Wright Healthcare Momentum ETF is an ETF - a fund traded on an exchange like a stock - run by Invesco. Positions inside: 56. The ten largest make up 37% of the fund.
- Yearly costs
- 0.74%
- Fund size
- $280.8M
- Positions
- 56
- Dividend yield
- 2.68%
- Running since
- 2006
What speaks for it
- Average yearly growth over the last ten years: 13%.
- It has been running since 2006.
What to watch
- 100% of the fund is in one sector (Healthcare).
- 95% of the fund is in one country (United States).
- Costs of 0.74% a year are above the middle of comparable funds (0.44%).
- In the last five years its price once dropped by 54% from its high.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- -7.0%
- 3 months
- -2.3%
- This year
- +14%
- 1 year
- +20%
- 3 years
- +88%
- 5 years
- +8.1%
- 10 years
- +247%
- Avg. market cap
- $12.7B
- P/E
- -
- Forward P/E
- -
- P/S
- 3.7x
- P/B
- 6.2x
- P/FCF
- 16.3x
- EV/EBITDA
- -
- Dividend yield
- 0.01%
- ROIC
- -8.2%
- ROE
- -2.3%
- Gross margin
- 43.6%
- Operating margin
- -1,302.8%
- Net margin
- -500.1%
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 0.97
Weighted average of the 50 largest companies, which make up 99% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Moderately concentrated- 1 IOIovance Biotherapeutics, Inc. IOVA 5.2%
- 2 THTenet Healthcare THC 3.9%
- 3 NTNatera NTRA 3.9%
- 4 GHGuardant Health GH 3.7%
- 5 RVRevolution Medicines RVMD 3.7%
- 6 TX10x Genomics, Inc. TXG 3.6%
- 7 RORoivant Sciences ROIV 3.6%
- 8 INInsmed INSM 3.2%
- 9 TWTwist Bioscience TWST 2.9%
- 10 MEMedpace MEDP 2.9%
Positions in the fund: 56. The ten largest make up 37% of it.
Composition as of Oct 17, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 100%
By country
- United States 95%
- United Kingdom 3.6%
- Netherlands 1.0%
By company size
- Large cap 36%
- Mid cap 53%
- Small cap 11%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.
Largest sector: Healthcare (100%). Largest country: United States (95%). Largest size group: Mid cap (53%).
What does it cost me?
Expensive- A year from $10,000
- $74.00
- Over 20 years
- $3,500
From every $10,000 invested the fund takes $74.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $3,500.
How has it done?
Growing over the long run- A year on average, 10 years
- +13%
- Deepest drop
- -54%
- Yearly volatility
- 27%
Average yearly growth over the last ten years: 13%. Deepest drop in these years: 54% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 2.68%
- Payments a year
- 1
- Last payment
- $1.53
Over the last 12 months it paid $1.53 per share, which is 2.68% of today's price. The last payment was $1.53 on Dec 22, 2025.
Is it easy to buy and sell?
Yes- Traded a day
- $2.99M
- Shares a day
- 53K
On an average day about $2.99M of the fund changes hands.
How expensive are the companies inside?
Rather expensive- Average Bulios Score
- 47 out of 100
Weight by Bulios Fair Price
- Undervalued 6.8%
- Fairly valued 9.5%
- Overvalued 84%
By Fair Price, 84% of the rated weight comes out as overvalued.
Counted from its largest companies (50), which make up 99% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
HL HLTH Tema Healthcare AI ETF | United States | 0.75% | $1.08M | - | - | 28% |
GN GNMX Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF | United States | 0.35% | $1.95M | - | - | 25% |
FM FMED Fidelity Disruptive Medicine ETF | United States | 0.50% | $69.3M | +16% | Pays out | 25% |
TD TDNA T. Rowe Price Biotech ETF | United States | 0.55% | $9.09M | - | - | 25% |
HE HELX Franklin Genomic Advancements ETF | United States | 0.50% | $32.9M | +22% | Pays out | 24% |
XB XBI SPDR S&P Biotech ETF | United States | 0.35% | $7.55B | +34% | Pays out | 23% |
